| Date | Time | Source | Headline | Symbol | Company |
| 07/11/2024 | 12:21PM | iHub Newswire | FeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing | | |
| 07/07/2011 | 8:16AM | Marketwired | MannKind and Amylin Embrace the Future of Diabetes Treatment | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/06/2011 | 4:11PM | Dow Jones News | UPDATE: How Lilly's Diabetes-Drug Alliance With Amylin Deteriorated | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/06/2011 | 1:24PM | Dow Jones News | How Lilly's Diabetes-Drug Alliance With Amylin Deteriorated | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/05/2011 | 4:33PM | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/01/2011 | 11:00AM | Zacks | NVO Presents Degludec Data - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/01/2011 | 10:30AM | Zacks | Encouraging Data Presented by ALKS - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/30/2011 | 9:45AM | Dow Jones News | 2nd UPDATE: Lilly Lays Out Plans To Weather Stormy Years Ahead | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/28/2011 | 11:15AM | Zacks | Novo Nordisk Presents Data - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/26/2011 | 9:03AM | Dow Jones News | Sanofi: New Diabetes Drug Shown To Work As Well As Byetta | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/24/2011 | 7:46PM | Dow Jones News | Amylin, MannKind Shares Rise On Diabetes Data Releases | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/24/2011 | 5:05PM | Business Wire | Once-Monthly Exenatide Improved Glucose Control in Patients with Type 2 Diabetes: Phase 2 Study Results Presented at ADA 2011 | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/24/2011 | 5:05PM | Business Wire | Analysis Shows BYDUREON™ Was Not Associated with Clinically Relevant QT Prolongation in Patients with Type 2 Diabetes: Resu... | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/24/2011 | 5:05PM | Business Wire | Studies Show Effect of BYDUREON™ on A1C and Weight for Up to Three Years | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/24/2011 | 5:00PM | PR Newswire (US) | Analysis Finds BYETTA® Associated with Lower Likelihood of Heart Failure Compared with Other Diabetes Therapies: Results Pre... | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/24/2011 | 5:00PM | PR Newswire (US) | Once-Monthly Exenatide Improved Glucose Control in Patients with Type 2 Diabetes: Phase 2 Study Results Presented at ADA 2011 | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/24/2011 | 5:00PM | PR Newswire (US) | Studies Show Effect of BYDUREON™ on A1C and Weight for Up to Three Years | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/24/2011 | 5:00PM | PR Newswire (US) | Analysis Provides New Insights Into Use of SYMLIN® in Patients With Type 1 Diabetes Using Insulin Pumps | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/24/2011 | 5:00PM | PR Newswire (US) | Analysis Shows BYDUREON™ Was Not Associated with Clinically Relevant QT Prolongation in Patients with Type 2 Diabetes: Resu... | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/23/2011 | 1:12PM | Zacks | Alkermes Evenly Poised - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/23/2011 | 1:12PM | Zacks | Alkermes Evenly Poised - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/22/2011 | 12:39PM | Zacks | Bydureon Gains EU Approval - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/22/2011 | 12:39PM | Zacks | Bydureon Gains EU Approval - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/22/2011 | 12:39PM | Zacks | Bydureon Gains EU Approval - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/21/2011 | 7:02AM | Dow Jones News | Lilly, Amylin, Alkermes Diabetes Drug Gets EU Approval | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/21/2011 | 6:13AM | PR Newswire (US) | BYDUREON™ RECEIVES MARKETING AUTHORIZATION IN EUROPE | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/20/2011 | 4:15PM | PR Newswire (US) | Amylin Pharmaceuticals to Present Promising New Data on the Company's Diabetes Programs at ADA 2011 | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/16/2011 | 11:12AM | Zacks | Eli Lilly Launches Tradjenta - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/13/2011 | 1:47PM | Dow Jones News | UPDATE: Forest Labs Discloses Icahn Attempt At Board Shakeup | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/09/2011 | 12:11PM | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |